Imaging characteristics of cardiac metastases in patients with malignant melanoma

by Tanja Zitzelsberger, Thomas K. Eigentler, Patrick Krumm, Konstantin Nikolaou, Claus Garbe, Meinrad Gawaz, Bernhard Klumpp
Published 2017-07-01

Effectiveness of carboplatin and paclitaxel as first- and second-line treatment in 61 patients with metastatic melanoma.

by Annette Pflugfelder, Thomas K Eigentler, Ulrike Keim, Benjamin Weide, Ulrike Leiter, Kristian Ikenberg, Mark Berneburg, Claus Garbe
Published 2011-01-01

Prognosis of sentinel node staged patients with primary cutaneous melanoma.

by Otmar Elsaesser, Ulrike Leiter, Petra G Buettner, Thomas K Eigentler, Friedegund Meier, Benjamin Weide, Gisela Metzler, Helmut Breuninger, Claus Garbe
Published 2012-01-01

BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapy.

by Diana Meckbach, Ulrike Keim, Sabina Richter, Ulrike Leiter, Thomas K Eigentler, Jürgen Bauer, Annette Pflugfelder, Petra Büttner, Claus Garbe, Benjamin Weide
Published 2014-01-01

Genome-Wide Association Study Suggests the Variant rs7551288*A within the <i>DHCR24</i> Gene Is Associated with Poor Overall Survival in Melanoma Patients

by Annette Pflugfelder, Xuan Ling Hilary Yong, Kasturee Jagirdar, Thomas K. Eigentler, H. Peter Soyer, Richard A. Sturm, Lukas Flatz, David L. Duffy
Published 2022-05-01

Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management

by Jan Leipe, Lucie Heinzerling, Thomas K Eigentler, Michael Fluck, Jessica C Hassel, Daniela Heller-Schenck, Matthias Pauschinger, Arndt Vogel, Lisa Zimmer, Ralf Gutzmer
Published 2019-06-01

Can Whole-Body Baseline CT Radiomics Add Information to the Prediction of Best Response, Progression-Free Survival, and Overall Survival of Stage IV Melanoma Patients Receiving Fir...

by Felix Peisen, Annika Gerken, Alessa Hering, Isabel Dahm, Konstantin Nikolaou, Sergios Gatidis, Thomas K. Eigentler, Teresa Amaral, Jan H. Moltz, Ahmed E. Othman
Published 2023-10-01

Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition

by Jessica C. Hassel, Lisa Zimmer, Thomas Sickmann, Thomas K. Eigentler, Friedegund Meier, Peter Mohr, Tobias Pukrop, Alexander Roesch, Dirk Vordermark, Christina Wendl, Ralf Gutzmer
Published 2023-06-01

Survival according to BRAF-V600 tumor mutations--an analysis of 437 patients with primary melanoma.

by Diana Meckbach, Jürgen Bauer, Annette Pflugfelder, Friedegund Meier, Christian Busch, Thomas K Eigentler, David Capper, Andreas von Deimling, Michel Mittelbronn, Sven Perner, Kristian Ikenberg, Markus Hantschke, Petra Büttner, Claus Garbe, Benjamin Weide
Published 2014-01-01

COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma

by Carola Berking, Elisabeth Livingstone, Dirk Debus, Carmen Loquai, Michael Weichenthal, Ulrike Leiter, Felix Kiecker, Peter Mohr, Thomas K. Eigentler, Janina Remy, Katharina Schober, Markus V. Heppt, Imke von Wasielewski, Dirk Schadendorf, Ralf Gutzmer
Published 2023-09-01

Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy

by Thomas K Eigentler, Teresa Amaral, Benjamin Weide, Graham Pawelec, Tobias Sinnberg, Claus Garbe, Lukas Flatz, Friedegund Meier, Kilian Wistuba-Hamprecht, Alfred Königsrainer, Oltin T Pop, Jonas Bochem, Henning Zelba, Janine Spreuer, Andrea Gaissler, Karolin Thiel, Can Yurttas, Daniel Soffel, Stephan Forchhammer, Heike Niessner, Markus W Löffler
Published 2021-12-01

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

by Markus V. Heppt, Teresa Amaral, Katharina C. Kähler, Lucie Heinzerling, Jessica C. Hassel, Markus Meissner, Nicole Kreuzberg, Carmen Loquai, Lydia Reinhardt, Jochen Utikal, Evelyn Dabrowski, Anja Gesierich, Claudia Pföhler, Patrick Terheyden, Kai-Martin Thoms, Lisa Zimmer, Thomas K. Eigentler, Michael C. Kirchberger, Henner M. Stege, Friedegund Meier, Max Schlaak, Carola Berking
Published 2019-11-01

UV-radiation and MC1R germline mutations are risk factors for the development of conventional and spitzoid melanomas in children and adolescentsResearch in context

by Alexandra Liebmann, Jakob Admard, Sorin Armeanu-Ebinger, Hannah Wild, Michael Abele, Axel Gschwind, Olga Seibel-Kelemen, Christian Seitz, Irina Bonzheim, Olaf Riess, German Demidov, Marc Sturm, Malou Schadeck, Michaela Pogoda, Ewa Bien, Malgorzata Krawczyk, Eva Jüttner, Thomas Mentzel, Maja Cesen, Elke Pfaff, Michal Kunc, Stephan Forchhammer, Andrea Forschner, Ulrike Leiter-Stöppke, Thomas K. Eigentler, Dominik T. Schneider, Christopher Schroeder, Stephan Ossowski, Ines B. Brecht
Published 2023-10-01

Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade

by Andrea Gaißler, Andrea Gaißler, Trine Sundebo Meldgaard, Christina Heeke, Sepideh Babaei, Siri Amanda Tvingsholm, Jonas Bochem, Jonas Bochem, Janine Spreuer, Janine Spreuer, Teresa Amaral, Teresa Amaral, Nikolaus Benjamin Wagner, Nikolaus Benjamin Wagner, Reinhild Klein, Friedegund Meier, Friedegund Meier, Claus Garbe, Thomas K. Eigentler, Graham Pawelec, Graham Pawelec, Manfred Claassen, Manfred Claassen, Benjamin Weide, Sine Reker Hadrup, Kilian Wistuba-Hamprecht, Kilian Wistuba-Hamprecht, Kilian Wistuba-Hamprecht
Published 2022-07-01

High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma

by Dirk Schadendorf, Thomas K Eigentler, Israel Lowy, Apostolos Papachristos, Samantha Bowyer, Friedegund Meier, Brigitte Dreno, Danny Rischin, Michael R Migden, Annette M Lim, Chrysalyne D Schmults, Brett G M Hughes, Axel Hauschild, Brian Stein, Emmanuel Okoye, Jocelyn Booth, Matthew G Fury, Alexander Guminski, Sophie Dalac, Frank Seebach, Marie Beylot-Barry, Suk-Young Yoo, Nicole Basset-Séguin, Sabiha Trabelsi Messai, Victoria Casado Echarren, Anne J Paccaly, Jenny-Hoa Nguyen
Published 2024-03-01

Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study

by Carola Berking, Thomas K Eigentler, Andrea Forschner, Georg Richtig, Erika Richtig, Stefan Diem, Benjamin Weide, Bernhard Klumpp, Claus Garbe, Lukas Flatz, Patrick Terheyden, Lydia Reinhardt, Friedegund Meier, Carmen Loquai, Ulrike Leiter, Van Anh Nguyen, Martin Röcken, Mirjana Ziemer, Nikolaus B Wagner, Max M Lenders, Kathrin Kühl, Fiona André, Milena Dudda, Natalie Ring, Chiara Ebel, Ramon Stäger, Caroline Zellweger, Roland Lang, Michael Paar, Philipp Gussek, Suzan H Stürmer, Susanne Kimeswenger, Angela Oellinger, Maximilian Gassenmaier, Amadeus Schraag, Wolfram Hoetzenecker, Johanna Mangana, Christoffer Gebhardt, Antonio Cozzio
Published 2021-05-01